By AP News
Photos: YouTube Screenshots\Wikimedia Commons
The Trump administration on Monday asked a judge to toss out a lawsuit from three Republican-led states seeking to cut off telehealth access to abortion medication mifepristone. Read more.
Why this matters:
Justice Department attorneys stayed the legal course charted by the Biden administration, though they didn’t directly weigh in on the underlying issue of access to the drug that’s part of the nation’s most common method of abortion. Rather, the government argued the states don’t have the legal right, or standing, to sue.
Trump told Time magazine in December he would not restrict access to abortion medication. The case is being considered by U.S. District Judge Matthew Kacsmaryk in Texas, a Trump nominee who once ruled in favor of halting approval for the drug.
The lawsuit from Idaho, Kansas, and Missouri, filed last year, argues that the Food and Drug Administration should roll back access to mifepristone. They want the FDA to prohibit telehealth prescriptions for mifepristone, require three in-office visits and restrict the point in a pregnancy when it can be used.
| RELATED COVERAGE ➤ |
